Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics and Intracanal Medications for Chronic Apical Periodontitis
NCT07683520Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Oct 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial in apical periodontitis (AP) (6 arms), sponsored by Ain Shams University. Primary endpoint: Receptor Activator of Nuclear Factor Kappa B Ligand and Osteoprotegerin Levels at 21 days. Started Oct 2025; status: completed.
02
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT07683520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683520.